| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health [H. F., R. T. J.], and National Cancer Institute-Navy Medical Oncology Branch, National Institutes of Health, Bethesda, Maryland 20892 [A. F. G., J-A. P., H. O.]
Studies demonstrate that some colon cancers possess receptors for various gastrointestinal hormones or neurotransmitters, the occupation of which can affect growth. These results are limited because frequently only a small number of tumors are studied, only 1 or 2 receptors are sought, and the effect on cell function is not investigated. In the present study, 10 recently characterized human colon cancer cell lines were studied to determine whether they possess receptors for any of 12 different gastrointestinal hormones or neurotransmitters and to determine whether these receptors mediate changes in cellular function. Each of the cell lines exhibited receptors for at least one radioligand. Receptors for vasoactive intestinal peptide (VIP) and muscarinic cholinergic agents occurred on 60%, bombesin and gastrin on 30%, ß-adrenergic agents and gastrin-releasing peptide (GRP) on 20%, and somatostatin, opiates, neuromedin B, and substance P on 10%. Analysis of [3H]N-methylscopolamine binding revealed a Kd of 0.2 nM for N-methylscopolamine with a binding capacity of 2500 sites/cell. With the agonist carbamylcholine, the receptor exhibited 2 classes of binding sites: one of high affinity (Kd 55 µM) representing 75% of the binding sites and one of low affinity (Kd 0.3 mM) representing 25% of the binding sites. Analysis of 125I-[Tyr4] bombesin binding revealed a receptor of high affinity (Kd 2.1 µM) with a binding capacity of 3300 sites/cell. Inhibition of binding by agonists revealed relative potencies of 125I-[Tyr4]bombesin > GRP >> neuromedin B, and two recently described antagonists were similar in potency to GRP. Analysis of 125I-VIP binding revealed a receptor having 2 classes of binding sites: one of high affinity (Kd 3.6 nM) and one of low affinity (Kd 1.7 µM) which represented the majority of the 5.5 x 106 binding sites/cell. The relative potencies of agonists were VIP > helodermin > peptide histidine methionine > secretin. Evaluation of biological activity mediated by the muscarinic cholinergic and bombesin receptors revealed an increase of intracellular calcium and of inositol triphosphate by specific receptor agonists. The presence or absence of receptors detected by binding correlated closely with the ability of selective receptor agonists to alter cell function. These results demonstrate the presence of several different receptors for gastrointestinal hormones or neurotransmitters, some described for the first time, on human colon cancer cell lines, including bombesin-related peptides, VIP, somatostatin, substance P, ß-adrenergic agents, calcitonin gene-related peptide, gastrin, muscarinic cholinergic agents, and opiates. These receptors are functional because occupation by selective agonists altered intracellular mediators. These results suggest that it will be important to extend these studies to evaluate growth effects.
1 Present address: Division of Oncologic Gastroenterology, Department of Medicine, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111.
2 To whom requests for reprints should be addressed, at National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Building 10, Room 9C-103, Bethesda, MD 20892.
Received 7/30/91. Accepted 12/13/91.
This article has been cited by other articles:
|
|
 |
|
  G. Xie, K. Cheng, J. Shant, and J.-P. Raufman Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G755 - G763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Shah, S. Khurana, K. Cheng, and J.-P. Raufman Muscarinic receptors and ligands in cancer Am J Physiol Cell Physiol, February 1, 2009; 296(2): C221 - C232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Cheng, R. Samimi, G. Xie, J. Shant, C. Drachenberg, M. Wade, R. J. Davis, G. Nomikos, and J.-P. Raufman Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G591 - G597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Raufman, R. Samimi, N. Shah, S. Khurana, J. Shant, C. Drachenberg, G. Xie, J. Wess, and K. Cheng Genetic Ablation of M3 Muscarinic Receptors Attenuates Murine Colon Epithelial Cell Proliferation and Neoplasia Cancer Res., May 15, 2008; 68(10): 3573 - 3578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Taglia, D. Matusiak, K. A. Matkowskyj, and R. V. Benya Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G182 - G190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Matusiak, S. Glover, R. Nathaniel, K. Matkowskyj, J. Yang, and R. V. Benya Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G718 - G728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-W. Koon, D. Zhao, X. Na, M. P. Moyer, and C. Pothoulakis Metalloproteinases and Transforming Growth Factor-{alpha} Mediate Substance P-induced Mitogen-activated Protein Kinase Activation and Proliferation in Human Colonocytes J. Biol. Chem., October 29, 2004; 279(44): 45519 - 45527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Cheng, P. Zimniak, and J.-P. Raufman Transactivation of the Epidermal Growth Factor Receptor Mediates Cholinergic Agonist-Induced Proliferation of H508 Human Colon Cancer Cells Cancer Res., October 15, 2003; 63(20): 6744 - 6750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Reubi Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy Endocr. Rev., August 1, 2003; 24(4): 389 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Calvert and H. Frucht The Genetics of Colorectal Cancer Ann Intern Med, October 1, 2002; 137(7): 603 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Igarashi, T. Ito, W. Hou, S. A. Mantey, T. K. Pradhan, C. D. Ulrich II, S. J. Hocart, D. H. Coy, and R. T. Jensen Elucidation of Vasoactive Intestinal Peptide Pharmacophore for VPAC1 Receptors in Human, Rat, and Guinea Pig J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 37 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Watson, P. A. Clarke, T. M. Morris, and M. E. Caplin Antiserum Raised against an Epitope of the Cholecystokinin B/Gastrin Receptor Inhibits Hepatic Invasion of a Human Colon Tumor Cancer Res., October 1, 2000; 60(20): 5902 - 5907. [Abstract] [Full Text]
|
|
|
|
 |
|
 W.-L. Yang and H. Frucht Cholinergic receptor up-regulates COX-2 expression and prostaglandin E2 production in colon cancer cells Carcinogenesis, October 1, 2000; 21(10): 1789 - 1793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Carroll, D. Ostrovskiy, S. Lee, A. Danilkovich, and R. V. Benya Characterization of Gastrin-Releasing Peptide and Its Receptor Aberrantly Expressed by Human Colon Cancer Cell Lines Mol. Pharmacol., September 1, 2000; 58(3): 601 - 607. [Abstract] [Full Text]
|
|
|
|
|
|
H. J. Kim, B. M. Evers, D. A. Litvak, M. R. Hellmich, and C. M. Townsend Jr. Signaling mechanisms regulating bombesin-mediated AP-1 gene induction in the human gastric cancer SIIA Am J Physiol Cell Physiol, August 1, 2000; 279(2): C326 - C334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Carroll, K. A. Matkowskyj, M. S. Tretiakova, J. F. Battey, and R. V. Benya Gastrin-releasing Peptide Is a Mitogen and a Morphogen in Murine Colon Cancer Cell Growth Differ., July 1, 2000; 11(7): 385 - 393. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Frucht, R. T. Jensen, D. Dexter, W.-L. Yang, and Y. Xiao Human Colon Cancer Cell Proliferation Mediated by the M3 Muscarinic Cholinergic Receptor Clin. Cancer Res., September 1, 1999; 5(9): 2532 - 2539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Carroll, K. A. Matkowskyj, S. Chakrabarti, T. J. McDonald, and R. V. Benya Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G655 - G665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Saurin, E. Nemoz-Gaillard, B. Sordat, J. C. Cuber, D. H. Coy, J. Abello, and J. A. Chayvialle Bombesin Stimulates Adhesion, Spreading, Lamellipodia Formation, and Proliferation in the Human Colon Carcinoma Isreco1 Cell Line Cancer Res., February 1, 1999; 59(4): 962 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Czerwinski, N. I. Tarasova, and C. J. Michejda Cytotoxic agents directed to peptide hormone receptors: Defining the requirements for a successful drug PNAS, September 29, 1998; 95(20): 11520 - 11525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G S BALDWIN and A SHULKES Gastrin, gastrin receptors and colorectal carcinoma Gut, April 1, 1998; 42(4): 581 - 584. [Full Text] [PDF]
|
|
|
|
|
|
Y.-S. Guo, M. R. Hellmich, X. D. Wen, and C. M. Townsend Jr. Activator Protein-1 Transcription Factor Mediates Bombesin-stimulated Cyclooxygenase-2 Expression in Intestinal Epithelial Cells J. Biol. Chem., June 15, 2001; 276(25): 22941 - 22947. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
